Provided herein is a single component sealant formulation (e.g. in a liquid form), methods for its preparation, and use. The formulation includes fibrinogen; vitamin K-dependent clotting zymogens comprising at least Factor II (FII) and Factor X (FX).
申请公布号
AU2014372151(A1)
申请公布日期
2016.06.30
申请号
AU20140372151
申请日期
2014.12.04
申请人
OMRIX BIOPHARMACEUTICALS LTD.;ETHICON, INC.
发明人
PILPEL, YAIR;DEANGLIS, ASHLEY;ZHERDEV, YURI;DORON, SIVAN;GORMAN, ANNE;NUR, ISRAEL
